# Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

Study · id `cardio:ct-nct02290028` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02290028](<https://clinicaltrials.gov/study/NCT02290028>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02290028

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 2226 participants.

## Technical summary

Registry record NCT02290028. Allocation not applicable; no masking; primary purpose other. Start 2014-12-16 (actual); primary completion 2020-01-23 (actual). Results posted on 2021-03-24.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 2226 participants (enrolled count; ClinicalTrials.gov record NCT02290028, source copy `cardio:ctgov-nct02290028-2021-03-24`, retrieved 2026-10-26)
- Started: 2014-12-16 (actual) (ClinicalTrials.gov record NCT02290028, source copy `cardio:ctgov-nct02290028-2021-03-24`, retrieved 2026-10-26)
- Primary completion: 2020-01-23 (actual) (ClinicalTrials.gov record NCT02290028, source copy `cardio:ctgov-nct02290028-2021-03-24`, retrieved 2026-10-26)
- Completion: 2020-01-23 (actual) (ClinicalTrials.gov record NCT02290028, source copy `cardio:ctgov-nct02290028-2021-03-24`, retrieved 2026-10-26)
- Results first posted: 2021-03-24 (ClinicalTrials.gov record NCT02290028, source copy `cardio:ctgov-nct02290028-2021-03-24`, retrieved 2026-10-26)
- Countries: United States; Australia; Austria; Denmark; Germany; Hungary; Israel; Italy; Slovakia; Spain; Switzerland (ClinicalTrials.gov record NCT02290028, source copy `cardio:ctgov-nct02290028-2021-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02290028-2021-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
- Acronym: QP ExCELs
- Condition: Heart Failure
- Intervention (Device): Sentus QP left ventricular lead
- Lead sponsor: Biotronik SE & Co. KG
- Lead sponsor class: INDUSTRY
- Collaborator: Biotronik, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)
- Registry lists this organization as a collaborator: Biotronik, Inc. (`cardio:org-biotronik-inc`)

## Provenance

Content hash: 48cf4a2cda2444472526cc3e3d4986ecae9caa85044cbd2d81effd770c271290
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
